… in cancer biology and tumor cell aggression. This review considers the potential role of
integrins in cancer … agents currently under consideration clinically and provides an insight into …

… been increasingly recognized as a hallmark of cancer cells. Consequently, much attention
has been directed toward the potential of statins as therapeutic agents in the oncological field. …

Vascular targeting agents (VTAs) for the treatment of cancer are designed to cause a rapid
and selective shutdown of the blood vessels of tumors. Unlike antiangiogenic drugs that …

… distinct antitumor vascular activity to make it a potentially attractive tool for cancer therapy. …
(3) has good potential as an anticancer agent in the treatment of colon cancer. The efficacy of …

A wide variety of studies in vitro, in vivo, and in clinical trials have demonstrated that the
chelator currently used to treat iron overload disease, desferrioxamine, has anti-proliferative …

… temporally related to the administration of therapeutic agents, because of the very small …
evidence for a causal relationship between cancer therapeutic agents and arterial thrombosis is …

Cancer prevention sometimes referred to as tertiary prevention or chemoprevention makes
use of specific xenobiotics or drugs to prevent, delay, or retard the development of cancer. …

… Concurrent use of AG and breast cancer therapeutic agents … breast cancer therapeutics
synergistically inhibited cancer … the breast cancer therapeutic agents investigated in this study. …

… TfR for the delivery of therapeutic agents into cancer cells. We provide a summary of the vast
types of anti-cancer drugs that have been delivered into cancer cells employing a variety of …

… Nutraceuticals are alternative therapeutic agents to control the colon cancer progression.
The nutraceuticals stimulate the normal metabolic function in colon cancer cells and regulate …